Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Zolpidem in Progressive Supranuclear Palsy

View through CrossRef
Progressive supranuclear palsy (PSP) is a progressive neurodegenerative disorder, characterized by motor symptoms, postural instability, personality changes, and cognitive impairment. There is no effective treatment for this disorder. Reduced neurotransmission of GABA in the striatum and globus pallidus may contribute to the symptoms of motor and cognitive symptoms seen in PSP. Zolpidem is a GABA agonist of the benzodiazepine subreceptor BZ1. Here a nondiabetic, normotensive case of PSP is (Progressive Supranuclear Palsy) described, which showed improvement in swallowing, speech, and gaze paresis after zolpidem therapy and possible mechanism of actions are discussed. However, more trials are needed with large number of patients to confirm the effectiveness of zolpidem in progressive supranuclear palsy.
Title: Zolpidem in Progressive Supranuclear Palsy
Description:
Progressive supranuclear palsy (PSP) is a progressive neurodegenerative disorder, characterized by motor symptoms, postural instability, personality changes, and cognitive impairment.
There is no effective treatment for this disorder.
Reduced neurotransmission of GABA in the striatum and globus pallidus may contribute to the symptoms of motor and cognitive symptoms seen in PSP.
Zolpidem is a GABA agonist of the benzodiazepine subreceptor BZ1.
Here a nondiabetic, normotensive case of PSP is (Progressive Supranuclear Palsy) described, which showed improvement in swallowing, speech, and gaze paresis after zolpidem therapy and possible mechanism of actions are discussed.
However, more trials are needed with large number of patients to confirm the effectiveness of zolpidem in progressive supranuclear palsy.

Related Results

Risks of suicide attempts after prescription of zolpidem in people with depression: a nationwide population study in South Korea
Risks of suicide attempts after prescription of zolpidem in people with depression: a nationwide population study in South Korea
AbstractObjectivesTo investigate the association between zolpidem prescription and suicide attempts in people with depressionMethodsA nationwide, population-based electronic medica...
O uso do Zolpidem no período da pandemia do COVID-19: uma revisão narrativa
O uso do Zolpidem no período da pandemia do COVID-19: uma revisão narrativa
A Organização Mundial da Saúde (OMS), em 30 de janeiro de 2020, declarou que o surto do novo coronavírus constituía uma Emergência de Saúde Pública de Importância Internacional (ES...
Maloklusi pada Penderita Cerebral Palsy
Maloklusi pada Penderita Cerebral Palsy
Cerebral palsy (CP) is a non-progressive disorder that affect the brain during the growth and development process. Various disorders in patients with cerebral palsy, such as dentoc...
Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration
Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration
Abstract TDP-43 is mislocalized from the nucleus and aggregates within the cytoplasm of affected neurons in cases of amyotrophic lateral sclerosis. TDP-43 pathology ...
Efficacy and Safety of Zolpidem for Focal Dystonia After Neurosurgical Treatments: A Retrospective Cohort Study
Efficacy and Safety of Zolpidem for Focal Dystonia After Neurosurgical Treatments: A Retrospective Cohort Study
Although there are several reports of the significant efficacy of zolpidem for treating dystonia, zolpidem is still considered an anecdotal treatment. Here, we evaluated the effica...
Othello syndrome as a presenting manifestation of progressive supranuclear palsy
Othello syndrome as a presenting manifestation of progressive supranuclear palsy
Background: Othello syndrome, or delusional jealously, has been reported to occur in a variety of psychiatric and neurologic disorders, but no cases have been described in patients...
Impact de l’ordonnance sécurisée sur la prescription du zolpidem
Impact de l’ordonnance sécurisée sur la prescription du zolpidem
Introduction : en avril 2017, le zolpidem a subi un changement de réglementation obligeant sa prescription sur ordonnance sécurisée. Cette mesure est la conséquence d’une surconsom...

Back to Top